Diabetic Peripheral Neuropathy: Current Epidemiology, Diagnostic Advances, Biomarkers, and Management Strategies.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search or meta-analysis
PubMed 42015589 · doi:10.1155/jdr/9080699
What was done
This narrative review summarizes the epidemiology, pathophysiology, diagnostic methods, emerging plasma and neuroimaging biomarkers, and clinical management strategies for diabetic peripheral neuropathy.
What was found
The authors report that diabetic peripheral neuropathy affects up to 50% of individuals with diabetes mellitus during their disease course and is also observed in prediabetic populations. No specific quantitative diagnostic performance numbers, effect sizes for treatments, or review-specific statistics are reported in the abstract.
Why it matters
The review synthesizes current diagnostic and therapeutic paradigms, highlighting that clinical management remains limited to symptomatic relief and glycemic control due to a lack of curative, disease-modifying therapies.
Limits
The abstract describes a broad narrative overview rather than a systematic review or meta-analysis. It provides no primary clinical data, no detailed search methodology, and no quantitative statistical outcomes.
Cited by
- supports Diabetic neuropathy occurs in more than 50% of diabetics at some point during their lifetime.